5-hydroxytryptamine (serotonin) receptor 2C
| GO Term | Evidence Code | PMID |
|---|---|---|
| behavioral fear response | ||
| intracellular calcium ion homeostasis | ||
| intracellular calcium ion homeostasis | ||
| G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | ||
| phospholipase C-activating G protein-coupled receptor signaling pathway |
| GO Term | Evidence Code | PMID |
|---|---|---|
| plasma membrane | ||
| plasma membrane | ||
| plasma membrane | ||
| external side of plasma membrane | ||
| cell surface |
| GO Term | Evidence Code | PMID |
|---|---|---|
| Gq/11-coupled serotonin receptor activity | ||
| Gq/11-coupled serotonin receptor activity | ||
| G protein-coupled serotonin receptor activity | ||
| G protein-coupled serotonin receptor activity | ||
| G protein-coupled serotonin receptor activity |
| InterPro |
|---|
| 5-hydroxytryptamine receptor family |
| G protein-coupled receptor, rhodopsin-like |
| GPCR, rhodopsin-like, 7TM |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:11983 | Prader-Willi syndrome | |
| DOID:9352 | type 2 diabetes mellitus |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025